Literature DB >> 3872626

In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene.

T Takeuchi, S Kobayashi, M Tanabe, T Fujiwara.   

Abstract

Bithionol, dichlorophene, and hexachlorophene, which are used in treating some helminthic infections, killed trophozoites of Giardia lamblia and Trichomonas vaginalis in modified BI-S-33 and Asami media, respectively. Virtually all G. lamblia and T. vaginalis cells were killed within 24 h with a 0.42 mM concentration of these compounds, except that 0.93 mM dichlorophene was required for sterilizing T. vaginalis in the same period. In modified BI-S-33 and Asami media from which bovine and human sera were omitted, respectively, the inhibitory actions of the compounds against in vitro growth of these protozoa were significantly enhanced. Trophozoites of G. lamblia and T. vaginalis could be killed in shorter than 10 min with 0.074 mM dichlorophene and 0.0025 mM hexachlorophene, respectively, in serum-free media. G. lamblia, which was incubated in the complete medium containing dichlorophene, showed a characteristic swelling of the ventral side which led to disruption of the parasite, whereas bithionol caused a thin crack in the cytoplasm of T. vaginalis incubated in Asami medium. The crack appeared to enlarge and result in vacuolization of T. vaginalis. These observations suggest that bithionol, dichlorophene, and hexachlorophene merit further evaluation to ascertain whether they are useful for treatment of giardiasis and trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872626      PMCID: PMC176206          DOI: 10.1128/AAC.27.1.65

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Metabolic studies on Trichomonas vaginalis.

Authors:  R WELLERSON; G DOSCHER; A B KUPFERBEG
Journal:  Ann N Y Acad Sci       Date:  1959-11-18       Impact factor: 5.691

2.  Bacteria-free cultivation of Trichomonas vaginalis.

Authors:  K ASAMI
Journal:  Kitasato Arch Exp Med       Date:  1952-10

3.  Trichomonas vaginalis: NADH oxidase activity.

Authors:  M Tanabe
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

4.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

5.  Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.

Authors:  D B Keister
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

Review 6.  Drug therapy: metronidazole.

Authors:  J Koch-Weser; P Goldman
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

7.  The rapid restoration of respiratory control to uncoupled mitochondria.

Authors:  E C Weinbach; J Garbus
Journal:  J Biol Chem       Date:  1966-08-25       Impact factor: 5.157

8.  Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.

Authors:  M Müller; J G Meingassner; W A Miller; W J Ledger
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

9.  The treatment of fasciolopsiasis with niclosamide and dichlorophen.

Authors:  M Idris; K M Rahman; M A Muttalib; A K Azad Khan
Journal:  J Trop Med Hyg       Date:  1980-04

10.  Lipid and carbohydrate metabolism of Giardia lamblia.

Authors:  E L Jarroll; P J Muller; E A Meyer; S A Morse
Journal:  Mol Biochem Parasitol       Date:  1981-02       Impact factor: 1.759

View more
  5 in total

1.  Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).

Authors:  Jason M Fritzler; Guan Zhu
Journal:  J Antimicrob Chemother       Date:  2011-12-13       Impact factor: 5.790

Review 2.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  The Action of the Hexokinase Inhibitor 2-deoxy-d-glucose on Cryptosporidium parvum and the Discovery of Activities against the Parasite Hexokinase from Marketed Drugs.

Authors:  Rana Eltahan; Fengguang Guo; Haili Zhang; Guan Zhu
Journal:  J Eukaryot Microbiol       Date:  2018-10-05       Impact factor: 3.346

4.  In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents.

Authors:  B Gordts; W Hemelhof; C Asselman; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

5.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.